Other
Bijlagen EBP plan
- Course
- Institution
Hierin zijn de bijlagen te vinden van het EBP verpleegplan dat ik op de longafdeling heb geschreven.
[Show more]
Seller
Follow
irmahoekstra1
Reviews received
Content preview
BIJLAGENInhoud
1 Medische voorgeschiedenis......................................................................................................................................................... 3
2 Uitwerking geneesmiddelen........................................................................................................................................................ 3
2.1 Acetylcysteïne........................................................................................................................................................................... 4
2.2 Trimbow...................................................................................................................................................................................... 4
2.3 cetomacrogol creme (FNA).................................................................................................................................................. 5
2.4 codeine......................................................................................................................................................................................... 5
2.5 dexamethason........................................................................................................................................................................... 5
2.6 gliclazide MGA........................................................................................................................................................................... 6
2.7 hypromellose............................................................................................................................................................................. 7
2.8 metformine................................................................................................................................................................................. 7
2.9 omeprazol MSR......................................................................................................................................................................... 7
2.10 oxazepam.................................................................................................................................................................................. 8
2.11 paracetamol-coffeïne........................................................................................................................................................... 9
2.12 rivaroxaban............................................................................................................................................................................. 9
2.13 ventolin (salbutamol)....................................................................................................................................................... 10
2.14 amoxiciline-clavulaanzuur.............................................................................................................................................. 11
2.15 digoxine.................................................................................................................................................................................. 11
2.16 atrovent.................................................................................................................................................................................. 12
2.17 loperamide............................................................................................................................................................................ 12
2.18 metoprolol tartraat............................................................................................................................................................ 13
2.19 valsartan-hydrochloorthiazide..................................................................................................................................... 13
3 uitgevoerde Onderzoeken.......................................................................................................................................................... 14
3.1 Laboratoriumwaarden bloed........................................................................................................................................... 14
3.2 Bloedgas uitslagen................................................................................................................................................................ 15
3.3 Keelkweken............................................................................................................................................................................. 15
3.4 sputumkweek......................................................................................................................................................................... 16
4 Scorelijst compleciteit van zorg............................................................................................................................................... 16
5 Uitwerking extra verpleegproblemen................................................................................................................................... 17
5.1 Therapieontrouw.................................................................................................................................................................. 17
5.2 Diarree....................................................................................................................................................................................... 18
5.3 Afwijkende mictie (incontinentie met onbekende oorzaak)................................................................................18
5.4 verminderde mobiliteit....................................................................................................................................................... 18
5.5 machteloosheid...................................................................................................................................................................... 18
5.6 Zelfzorgtekort......................................................................................................................................................................... 18
, 5.7 Risico op verminderde ademhaling............................................................................................................................... 18
5.8 Risico op decubitus............................................................................................................................................................... 18
5.9 besmetting.............................................................................................................................................................................. 19
5.10 risico op verminderde cardiac output........................................................................................................................ 19
5.11 Risico op instabiele glucosewaarden.......................................................................................................................... 19
5.12 risico op vallen..................................................................................................................................................................... 19
5.13 obesitas................................................................................................................................................................................... 19
5.14 verstoorde slaap................................................................................................................................................................. 19
5.15 Risico op diep-veneuze trombose................................................................................................................................ 20
6 EBP...................................................................................................................................................................................................... 20
6.1 artikel 1..................................................................................................................................................................................... 20
6.2 artikel 2..................................................................................................................................................................................... 21
6.3 artikel 3..................................................................................................................................................................................... 22
6.4 artikel 4..................................................................................................................................................................................... 22
7 Hospital anxiety and depression scale.................................................................................................................................. 24
8 referenties........................................................................................................................................................................................ 26
, 1 MEDISCHE VOORGESCHIEDENIS
Geen datum Essentiele hypertensie
Geen datum Diabetes Mellitus type 2
2009 Diep veneuze trombose (DVT) na voetoperatie
2015 Amblyopie OD Lui rechter oog (Amblyopie: Een Lui Oog | Gezondheidsnet,
n.d.).
OD = oculus dextra (Afkortingen Oogzorg | Optometristen
Vereniging Nederland (OVN), n.d.).
2016 Totale knieprothese links
2017 Dry eye syndrome
2020 COPD gold II met lage ziektelast
2022 Juli Gemetastaseerd T3 betekent dat de tumor een grootte heeft tussen vijf en zeven
NSCLC centimeter(Niet Kleincellig Longcarcinoom - TNM Classificatie -
Richtlijn - Richtlijnendatabase, n.d.).
cT3N3M1c
De N-term geeft de mate van lymfeklierinfasie aan (node). N3
PD-L1 75% betekent dat het eigenlijk in alle omliggende klieren is
gevonden. De M-term geeft de mate van metastasering aan in
overige organen. M1c betekent dat er meerdere metastasen
buiten de thoraxholte zijn aangetroffen (in één of meerdere
organen). PD-L1 is een biomarker voor longkanker. Het is een
membraan-eiwit van een longkankercel, waardoor deze slecht
vindbaar is voor het immuunsysteem. Het percentage wijst
naar de hoeveelheid cellen van de tumor die dit eiwit tot
expressie brengen. Op basis hiervan wordt bepaald of
immunotherapie kan aanslaan (Biomarkers bij longkanker -
MSD, z.d.).
Augustus Start In verband met malaise en afvallen is gestart met deze
pembrolizumab antilichaam-therapie. Aangezien de PD-L1 hoger was dan 50%
en prednison wordt behandeling met pembrolizumab gestart(Vragen en
antwoorden over immuuntherapie | Longkanker Nederland, z.d.).
2023 Januari Progressie van NSCLC ondanks immunotherapie. Daarom wordt er gestopt met de
pembrolizumab en gestart met palliatieve radiotherapie.
2 UITWERKING GENEESMIDDELEN
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller irmahoekstra1. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $4.83. You're not tied to anything after your purchase.
Can Stuvia be trusted?
4.6 stars on Google & Trustpilot (+1000 reviews)
67096 documents were sold in the last 30 days
Founded in 2010, the go-to place to buy study notes for 14 years now